|
1
|
Names
of Reporting Persons
I.R.S.
Identification Nos. of above persons (entities only).
Hal
Pettigrew
|
||
|
2
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [
x ]
|
||
|
3
|
SEC
Use Only
|
||
|
4
|
Citizenship
or Place of Organization
United
States of America
|
||
|
Number
of Shares
Beneficially
Owned
by Each
Reporting
Person
With:
|
5
|
Sole
Voting Power
1,633,650
|
|
|
6
|
Shared
Voting Power
12,000
|
||
|
7
|
Sole
Dispositive Power
1,633,650
|
||
|
8
|
Shared
Dispositive Power
12,000
|
||
|
9
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
1,645,650
|
||
|
10
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
|
||
|
11
|
Percent
of Class Represented by Amount in Row (9)
5.48%
|
||
|
12
|
Type
of Reporting Person (See Instructions)
IN
|
||
|
Item
1(a)
|
Name
of Issuer:
|
|
|
Nymox
Pharmaceutical Corporation
|
||
|
Item
1(b)
|
Address
of Issuer’s Principal Executive Offices:
|
|
|
9900
Cavendish Blvd.
|
||
|
St.
Lauren, QC, Canada H4M 2V2
|
||
|
Item
2(a)
|
Names
of Person Filing:
|
|
|
Hal
Pettigrew
|
||
|
Item
2(b)
|
Address
of Principal Business Office or, if none, Residence:
|
|
|
2311
Cedar Springs Road, Suite 100, Dallas, Texas 75201
|
||
|
Item
2(c)
|
Citizenship:
|
|
|
United
States of America
|
||
|
Item
2(d)
|
Title
of Class of Securities:
|
|
|
Common
Shares
|
||
|
Item
2(e)
|
CUSIP
Number:
|
|
|
67076P102
|
||
|
Item
3.
|
If
this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or
(c), check whether the person filing is a:
|
|
|
Not
Applicable.
|
||
|
Item
4.
|
Ownership
|
|
|
Provide
the following information regarding the aggregate number and percentage of
the class of securities of the issuer identified in Item
1.
|
||
|
(a)
|
Amount Beneficially
Owned: 1,645,650 shares
|
|
|
(b)
|
Percent of
Class: 5.48%
|
|
|
(c)
|
Number
of shares as to which the person has:
|
|
|
(i) Sole
power to vote or to direct the vote
|
1,633,650
|
|
|
(ii) Shared
power to vote or to direct the vote
|
12,000
|
|
|
(iii) Sole
power to dispose or to direct the disposition of
|
1,633,650
|
|
|
(iv) Shared
power to dispose or to direct the disposition of
|
12,000
|
|
|
Item
5.
|
Ownership
of Five Percent or Less of a Class
|
|
|
If
this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following
[ ].
|
||
|
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another Person
|
|
|
The
reporting person beneficially owns an aggregate of 1,645,650 common shares
(the “Shares”) of the Issuer, which includes the following Shares in which
the reporting may be deemed to have shared voting or dispositive
power: (i) 275,400 Shares held in or managed by various trusts,
of which 12,000 Shares are held in trusts in which the reporting person is
co-trustee, and (ii) 242,600 Shares held by a profit sharing plan in which
the reporting person has an
interest.
|
||
|
Item
7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding Company or Control
Person
|
|
Not
Applicable.
|
|
|
Item
8.
|
Identification
and Classification of Members of the Group
|
|
Not
Applicable.
|
|
|
Item
9.
|
Notice
of Dissolution of Group
|
|
Not
Applicable.
|
|
|
Item
10.
|
Certifications
|
|
(a) Not
Applicable.
|
|
|
(b) By
signing below, I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose
or effect.
|